Discuss the latest strategies to harness the immune system for the development of innovative therapeutics
Emerging T Cell Therapy Company NexImmune Receives First IND Clearance for Phase 1/2 Trial in Acute Myeloid Leukemia / Myelodysplastic Syndrome
Emerging T Cell Therapy Company NexImmune Receives First IND Clearance for Phase 1/2 Trial in Acute Myeloid Leukemia / Myelodysplastic Syndrome October 31, 2019 07:30 ET | Source: NexImmune, Inc. IND clearance enables [….]
Immune-oncology Leaders Converge on Montgomery College for Bio-Trac’s Multiplex Immunofluorescence Symposium
Immune-oncology Leaders Converge on Montgomery College for Bio-Trac’s Multiplex Immunofluorescence Symposium
Local Entrepreneur Brings Swedish Company AcouSort to BioHealth Capital Region
Local Entrepreneur Brings Swedish Company AcouSort to BioHealth Capital Region February 26, 2019 For every AstraZeneca, there are hundreds of small biotech startups and scores of life science innovators that [….]
Q&A with Jaime Rodriguez-Canales, M.D., FEBP – The importance of Multiplex Immunofluorescence in the field of Immune-Oncology
Q&A with Jaime Rodriguez-Canales, M.D., FEBP Dr. Rodriguez-Canales is a Senior Pathologist at MedImmune, and Course Director for the recent Multiplex Immunofluorescence in Immune-Oncology Symposium, a Bio-Trac program cosponsored by [….]
New Technology Impacting Immune-Oncology Research Attracts National Audience at First Annual Bio-Trac Symposium
Immune-Oncology Symposium